23 September 2029 07:00 BST AstraZeneca today announced that Qtrilmet (metformin hydrochloride, saxagliptin and dapagliflozin) modified-release tablets have been recommended for marketing authorisation in ……
September 20, 2029 ― Almirall LLC announced today the FDA approval of the expanded indication for Aczone? 7.5% Gel to include patients aged 9-22. Aczone? 7.5% Gel is a prescription medicine used on the skin (topical) to ……
Aug. 30, 2029 -- CARsgen Therapeutics Inc., a clinical-stage biopharmaceutical company today announced the United States Food and Drug Administration (FDA) has granted orphan drug designation to its investiga……
ORTH CHICAGO, Illinois, Aug. 2, 2029 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced that the European Commission has granted marketing authorization for MAVIRET? (……
JERUSALEM and PARSIPPANY, N.J., July 25, 2029 ? Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that the U.S. Food and Drug Administration (FDA) has approved AirDuo? Digihaler? (flutic……
July 2, 2029 - The European Commission (EC) has granted conditional marketing authorization for Libtayo? (cemiplimab) for the treatment of adults with metastatic or locally advanced cutaneous squamous cell carcinoma (CSC……
Copyright Nanjing Dorra Pharmaceutical Technology Co.,Ltd. @ 2018 China All Rights Reserved 苏ICP备12056923号-1
Tel: 025-82232955 025-82232966
Fax:025-82232933 025-82232944
E-mail: info@dorrapharma.com
